Sidley is advising BDT & MSD Partners in connection with their AU$1.6 billion investment in DBG Health, a leading Australian beauty and pharmaceutical company. This strategic investment values DBG Health at approximately AU$7 billion and includes up to AU$1 billion of additional funding for future acquisitions, making this one of the largest private founder-led transactions in Australian corporate history.
The Sidley team is led by David Perkins and Rob Garritano (M&A and Private Equity), and includes Louis Jennings and Adi Milstein (M&A and Private Equity); Noam Waltuch, Rachel Kleinberg, and Andy Lau (Tax); Diane McEnroe, Deeona Gaskin, Susan Stolzer, and Kelly Cho (Food, Drug and Medical Device); Chad Ehrenkranz, George Maliha M.D., and Jenna Hoskison (Healthcare); and Vadim Brusser and Mary Marks (Antitrust and Competition).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
